Literature DB >> 22138602

Clinical characteristics and outcomes of diabetic patients who were hospitalised with 2009 pandemic influenza A H1N1 infection.

Marta Cortes Garcia1, Maria Jose Sierra Moros, Patricia Santa-Olalla Peralta, Valentin Hernandez-Barrera, Rodrigo Jimenez-Garcia, Isabel Pachon.   

Abstract

OBJECTIVES: To describe demographic and clinical data and outcomes of severe cases of 2009 pandemic influenza A H1N1 (pH1N1) infections for persons with diabetes.
METHODS: We selected all person with diabetes (N = 252) among severe laboratory confirmed cases reported to the Spanish Surveillance System for detection of pH1N1 from June through December, 2009. One patient without diabetes matched by age and sex was selected. Collected variables included demographic characteristics, underlying medical conditions, outcome, clinical course and treatment.
RESULTS: Among those suffering diabetes only 15.9% did not report any other underlying condition. 38% of diabetic patients and 27.4% of non diabetic patients were admitted to ICU (p = 0.008). Thirty subjects suffering diabetes and fifteen without the disease died (11.9% vs. 6%[p = 0.019]). Multivariable analysis showed that the independent risk factors for ICU admission or death were suffering cardiovascular disease (OR = 2.28), morbid obesity (OR = 2.08) and antiviral treatment started after 48 h of onset of symptoms (OR = 1.89). Suffering diabetes was not independent risk factors for ICU admission or death after adjusting for covariates.
CONCLUSIONS: The worse outcome among diabetes sufferers could be a consequence of the higher prevalence of comorbid underlying medical conditions but not diabetes itself. Further prospective studies are needed to verify these results.
Copyright © 2011 The British Infection Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22138602     DOI: 10.1016/j.jinf.2011.11.022

Source DB:  PubMed          Journal:  J Infect        ISSN: 0163-4453            Impact factor:   6.072


  12 in total

1.  Working-age adults with diabetes experience greater susceptibility to seasonal influenza: a population-based cohort study.

Authors:  Darren Lau; Dean T Eurich; Sumit R Majumdar; Alan Katz; Jeffrey A Johnson
Journal:  Diabetologia       Date:  2014-02-06       Impact factor: 10.122

2.  Epidemiological characteristics and underlying risk factors for mortality during the autumn 2009 pandemic wave in Mexico.

Authors:  Gerardo Chowell; Santiago Echevarría-Zuno; Cécile Viboud; Lone Simonsen; Mark A Miller; Irma Fernández-Gárate; Cesar González-Bonilla; Víctor H Borja-Aburto
Journal:  PLoS One       Date:  2012-07-16       Impact factor: 3.240

3.  Impaired clearance of influenza A virus in obese, leptin receptor deficient mice is independent of leptin signaling in the lung epithelium and macrophages.

Authors:  Kathryn A Radigan; Luisa Morales-Nebreda; Saul Soberanes; Trevor Nicholson; Recep Nigdelioglu; Takugo Cho; Monica Chi; Robert B Hamanaka; Alexander V Misharin; Harris Perlman; G R Scott Budinger; Gökhan M Mutlu
Journal:  PLoS One       Date:  2014-09-18       Impact factor: 3.240

4.  Prevalence of Diabetes in the 2009 Influenza A (H1N1) and the Middle East Respiratory Syndrome Coronavirus: A Systematic Review and Meta-Analysis.

Authors:  Alaa Badawi; Seung Gwan Ryoo
Journal:  J Public Health Res       Date:  2016-12-21

5.  Influenza Virus and Glycemic Variability in Diabetes: A Killer Combination?

Authors:  Katina D Hulme; Linda A Gallo; Kirsty R Short
Journal:  Front Microbiol       Date:  2017-05-22       Impact factor: 5.640

Review 6.  Human Influenza Virus Infections.

Authors:  Christin Peteranderl; Susanne Herold; Carole Schmoldt
Journal:  Semin Respir Crit Care Med       Date:  2016-08-03       Impact factor: 3.119

Review 7.  The triumvirate: why hypertension, obesity, and diabetes are risk factors for adverse effects in patients with COVID-19.

Authors:  Harsh Shah; Md Shahjalal Hossain Khan; Nikhil V Dhurandhar; Vijay Hegde
Journal:  Acta Diabetol       Date:  2021-02-15       Impact factor: 4.280

8.  Clinical characteristics and risk factors for disease severity and mortality of COVID-19 patients with diabetes mellitus in Kazakhstan: A nationwide study.

Authors:  Azhar Dyusupova; Raida Faizova; Oksana Yurkovskaya; Tatiana Belyaeva; Tatiana Terekhova; Amina Khismetova; Antonio Sarria-Santamera; Dmitry Bokov; Alexandr Ivankov; Natalya Glushkova
Journal:  Heliyon       Date:  2021-03-19

9.  Clinical course and outcomes of COVID-19 patients with a history of cerebrovascular disease: a retrospective study in Wuhan.

Authors:  Yang Bai; Yong Liang; Fang Wang; Ligang Chen; Yulong Zhao; Shoujie Zhao; Yejing Zhu; Yushu Dong; Guobiao Liang; Dongfeng Chen; Lei Liu
Journal:  Ann Transl Med       Date:  2021-06

10.  Hospitalizations from pandemic Influenza [A(H1N1)pdm09] infections among type 1 and 2 diabetes patients in Spain.

Authors:  Rodrigo Jiménez-García; Valentín Hernández-Barrera; Cristina Rodríguez-Rieiro; Ana Lopez de Andres; Javier de Miguel-Diez; Isabel Jimenez-Trujillo; Angel Gil de Miguel; Pilar Carrasco-Garrido
Journal:  Influenza Other Respir Viruses       Date:  2012-08-07       Impact factor: 4.380

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.